19F MRI tracer preserves in vitro and in vivo properties of hematopoietic stem cells

Cell Transplantation

Volumn 22, Issue 1, 2013, Pages 87-97

  Helfer, Brooke M ^a   Balducci, Anthony ^a   Sadeghi, Zhina ^b   O'Hanlon, Charles ^a   Hijaz, Adonis ^b   Flask, Chris A ^c   Wesa, Amy ^a  

^a Two Gateway Center ^*  (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Cell tracking; Contrast agent; Magnetic resonance imaging (MRI) tracer; Preclinical safety; Stem cell therapy

Indexed keywords

CD34 ANTIGEN; FLUORINE; FLUOROCARBON; TRACER; CONTRAST MEDIUM;

ANIMAL CELL; ARTICLE; BONE MARROW; CELL FUNCTION; CELL VIABILITY; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MULTIPOTENT STEM CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOT STUDY; PRIORITY JOURNAL; RAT; ANIMAL; C57BL MOUSE; CHEMISTRY; CYTOLOGY; METHODOLOGY; MOUSE; PROCEDURES;

ANIMALS; CONTRAST MEDIA; FEMALE; FLUORINE; HEMATOPOIETIC STEM CELLS; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C57BL;

EID: 84873025317     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X653174     Document Type: Article

References (45)

1. Ahrens, E. T.; Flores, R.; Xu, H. Y.; Morel, P. A. In vivo imaging platform for tracking immunotherapeutic cells. Nat. Biotechnol. 23(8):983-987; 2005.
2. Arbab, A. S.; Yocum, G. T.; Kalish, H.; Jordan, E. K.; Anderson, S. A.; Khakoo, A. Y.; Read, E. J.; Frank, J. A. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 104(4):1217-1223; 2004.
3. Arbab, A. S.; Yocum, G. T.; Rad, A. M.; Khakoo, A. Y.; Fellowes, V.; Read, E. J.; Frank, J. A. Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed. 18(8):553-559; 2005.
4. 19F magnetic resonance imaging. PLoS One 6(12): e29040; 2011.
5. Bonetto, F.; Srinivas, M.; Heerschap, A.; Mailliard, R.; Ahrens, E. T.; Figdor, C. G.; de Vries, I. J. A novel (19)F agent for detection and quantification of human dendritic cells using magnetic resonance imaging. Int. J. Cancer 129(2):365-373; 2011.
6. Breems, D. A.; Blokland, E. A.; Neben, S.; Ploemacher, R. E. Frequency analysis of human primitive haematopoietic stem cell subsets using a cobblestone area forming cell assay. Leukemia 8(7):1095-1104; 1994.
7. Bulte, J. W. In vivo MRI cell tracking: Clinical studies. AJR. Am. J. Roentgenol. 193(2):314-325; 2009.
8. Chavakis, E.; Urbich, C.; Dimmeler, S. Homing and engraftment of progenitor cells: A prerequisite for cell therapy. J. Mol. Cell. Cardiol. 45(4):514-522; 2008.
9. Clarke, E.; Pereira, C.; Chaney, R.; Woodside, S.; Eaves, A. C.; Damen, J. Toxicity testing using hematopoietic stem cell assays. Regen. Med. 2(6):947-956; 2007.
10. Crabbe, A.; Vandeputte, C.; Dresselaers, T.; Sacido, A. A.; Verdugo, J. M.; Eyckmans, J.; Luyten, F. P.; Van Laere, K.; Verfaillie, C. M.; Himmelreich, U. Effects of MRI contrast agents on the stem cell phenotype. Cell Transplant. 19(8):919-936; 2010.
11. Fink, Jr., D. W. FDA regulation of stem cell-based products. Science 324(5935):1662-1663; 2009.
12. Helfer, B. M.; Balducci, A.; Nelson, A. D.; Janjic, J. M.; Gil, R. R.; Kalinski, P.; IJ, M. d. V.; Ahrens, E. T.; Mailliard, R. B. Functional assessment of human dendritic cells labeled for in vivo (19)F magnetic resonance imaging cell tracking. Cytotherapy 12(2):238-250; 2010.
13. Hennig, J.; Nauerth, A.; Friedburg, H. RARE imaging-a fast imaging method for clinical mr. Magn. Reson. Med. 3(6):823-833; 1986.
14. Hinds, K. A.; Hill, J. M.; Shapiro, E. M.; Laukkanen, M. O.; Silva, A. C.; Combs, C. A.; Varney, T. R.; Balaban, R. S.; Koretsky, A. P.; Dunbar, C. E. Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood 102(3):867-872; 2003.
15. Hofmann, M.; Wollert, K. C.; Meyer, G. P.; Menke, A.; Arseniev, L.; Hertenstein, B.; Ganser, A.; Knapp, W. H.; Drexler, H. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111(17):2198-2202; 2005.
16. Hou, D.; Youssef, E. A.; Brinton, T. J.; Zhang, P.; Rogers, P.; Price, E. T.; Yeung, A. C.; Johnstone, B. H.; Yock, P. G.; March, K. L. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: Implications for current clinical trials. Circulation 112(9 Suppl):I150-156; 2005.
17. Hoyes, K. P.; Wadeson, P. J.; Murby, B.; Sharma, H. L.; Cowan, R. A.; Lord, B. I. Bone marrow toxicity in mice treated with indium-114m-labelled blood cells. J. Exp. Clin. Cancer Res. 20(4):505-510; 2001.
18. Janjic, J. M.; Srinivas, M.; Kadayakkara, D. K. K.; Ahrens, E. T. Self-delivering nanoemulsions for dual fluorine-19 MRI and fluorescence detection. J. Am. Chem. Soc. 130(9):2832-2841; 2008.
19. Kadayakkara, D. K.; Beatty, P. L.; Turner, M. S.; Janjic, J. M.; Ahrens, E. T.; Finn, O. J. Inflammation driven by overexpression of the hypoglycosylated abnormal mucin 1 (MUC1) links inflammatory bowel disease and pancreatitis. Pancreas 39(4):510-515; 2010.
20. Kadayakkara, D. K.; Janjic, J. M.; Pusateri, L. K.; Young, W. B.; Ahrens, E. T. In vivo observation of intracellular oximetry in perfluorocarbon-labeled glioma cells and chemotherapeutic response in the CNS using fluorine-19 MRI. Magn. Reson. Med. 64(5):1252-1259; 2010.
21. Keller, L. H. Bone marrow-derived aldehyde dehydroge nase-bright stem and progenitor cells for ischemic repair. Congest. Heart Fail. 15(4):202-206; 2009.
22. Lee, J. K.; Lee, M. K.; Jin, H. J.; Kim, D. S.; Yang, Y. S.; Oh, W.; Yang, S. E.; Park, T. S.; Lee, S. Y.; Kim, B. S.; Jeun, S. S. Efficient intracytoplasmic labeling of human umbilical cord blood mesenchymal stromal cells with ferumoxides. Cell Transplant. 16(8):849-857; 2007.
23. Lewin, M.; Carlesso, N.; Tung, C. H.; Tang, X. W.; Cory, D.; Scadden, D. T.; Weissleder, R. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 18(4):410-414; 2000.
24. Li, L. H.; McCarthy, P.; Hui, S. W. High-efficiency electrotransfection of human primary hematopoietic stem cells. FASEB J. 15(3):586-588; 2001.
25. Martens, T. P.; Godier, A. F.; Parks, J. J.; Wan, L. Q.; Koeckert, M. S.; Eng, G. M.; Hudson, B. I.; Sherman, W.; Vunjak-Novakovic, G. Percutaneous cell delivery into the heart using hydrogels polymerizing in situ. Cell Transplant. 18(3):297-304; 2009.
26. Moore, K. A.; Ema, H.; Lemischka, I. R. In vitro maintenance of highly purified, transplantable hematopoietic stem cells. Blood 89(12):4337-4347; 1997.
27. Niemeyer, M.; Oostendorp, R. A.; Kremer, M.; Hippauf, S.; Jacobs, V. R.; Baurecht, H.; Ludwig, G.; Piontek, G.; Bekker-Ruz, V.; Timmer, S.; Rummeny, E. J.; Kiechle, M.; Beer, A. J. Non-invasive tracking of human haemopoietic CD34(+) stem cells in vivo in immunodeficient mice by using magnetic resonance imaging. Eur. Radiol. 20(9):2184-2193; 2010.
28. Nohroudi, K.; Arnhold, S.; Berhorn, T.; Addicks, K.; Hoehn, M.; Himmelreich, U. In vivo MRI stem cell tracking requires balancing of detection limit and cell viability. Cell Transplant. 19(4):431-441; 2010.
29. Nowak, B.; Weber, C.; Schober, A.; Zeiffer, U.; Liehn, E. A.; von Hundelshausen, P.; Reinartz, P.; Schaefer, W. M.; Buell, U. Indium-111 oxine labelling affects the cellular integrity of haematopoietic progenitor cells. Eur. J. Nucl. Med. Mol. Imaging 34(5):715-721; 2007.
30. Osawa, M.; Hanada, K.; Hamada, H.; Nakauchi, H. Longterm lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273(5272):242-245; 1996.
31. 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. FASEB J. 21(8):1647-1654; 2007.
32. Pessina, A.; Malerba, I.; Gribaldo, L. Hematotoxicity testing by cell clonogenic assay in drug development and preclinical trials. Curr. Pharm. Des. 11(8):1055-1065; 2005.
33. Prasad, V. K.; Kurtzberg, J. Cord blood and bone marrow transplantation in inherited metabolic diseases: Scientific basis, current status and future directions. Br. J. Haematol. 148(3):356-372; 2010.
34. Salama, H.; Zekri, A. R.; Zern, M.; Bahnassy, A.; Loutfy, S.; Shalaby, S.; Vigen, C.; Burke, W.; Mostafa, M.; Medhat, E.; Alfi, O.; Huttinger, E. Autologous hematopoietic stem cell transplantation in 48 patients with end-stage chronic liver diseases. Cell Transplant. 19(11):1475-1486; 2010.
35. 19F MRI and optical imaging. Biomaterials 31(27):7070-7077; 2010.
36. Srinivas, M.; Heerschap, A.; Ahrens, E. T.; Figdor, C. G.; de Vries, I. J. (19)F MRI for quantitative in vivo cell tracking. Trends Biotechnol. 28(7):363-370; 2010.
37. Srinivas, M.; Morel, P. A.; Ernst, L. A.; Laidlaw, D. H.; Ahrens, E. T. Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model. Magn. Reson. Med. 58:725-734; 2007.
38. Srinivas, M.; Turner, M. S.; Janjic, J. M.; Morel, P. A.; Laidlaw, D. H.; Ahrens, E. T. In vivo cytometry of antigenspecific t cells using F-19 MRI. Magn. Reson. Med. 62(3):747-753; 2009.
39. Terrovitis, J. V.; Smith, R. R.; Marban, E. Assessment and optimization of cell engraftment after transplantation into the heart. Circ. Res. 106(3):479-494; 2010.
40. Todd, D. M. Celsense, Pitt trial to 'see' cells fight cancer. Pittsburgh Post-Gazette. Pittsburgh, PA; 2011.
41. Treleaven, J.; Barrett, A. J. Hematopoietic stem cell transplantation in clinical practice. Edinburgh, New York: Elsevier; 2008.
42. Verdijk, P.; Aarntzen, E. H.; Lesterhuis, W. J.; Boullart, A. C.; Kok, E.; van Rossum, M. M.; Strijk, S.; Eijckeler, F.; Bonenkamp, J. J.; Jacobs, J. F.; Blokx, W.; Vankrieken, J. H.; Joosten, I.; Boerman, O. C.; Oyen, W. J.; Adema, G.; Punt, C. J.; Figdor, C. G.; de Vries, I. J. Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients. Clin. Cancer Res. 15(7):2531-2540; 2009.
43. Wineman, J.; Moore, K.; Lemischka, I.; Muller-Sieburg, C. Functional heterogeneity of the hematopoietic microenvironment: Rare stromal elements maintain long-term repopulating stem cells. Blood 87(10):4082-4090; 1996.
44. + cells by electroporation. Bone Marrow Transplant. 27(11):1201-1209; 2001.
45. Zhang, S. J.; Wu, J. C. Comparison of imaging techniques for tracking cardiac stem cell therapy. J. Nucl. Med. 48(12):1916-1919; 2007.